Mass. Supremes: Pharma Cos. liable for generic labeling issues

Merck (NYSE:MRK) and other large brand-name pharmaceutical manufacturers could be legally liable for injuries resulting not from the use of their brand name products, but from generic versions of those drugs made by other companies, according to a new ruling from the Massachusetts Supreme Judicial Court. The court ruling could set the precedent that such brand-name pharma companies could be found liable for reckless behavior if they fail to update labeling for their products which are also used for generic versions, according to court documents. Read the whole story on our sister site, Drug Delivery Business The post Mass. Supremes: Pharma Cos. liable for generic labeling issues appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Legal News Pharmaceuticals Merck Source Type: news